Copyright
©The Author(s) 2018.
World J Gastroenterol. Oct 28, 2018; 24(40): 4586-4595
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4586
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4586
Figure 3 Secondary cancer site analysis for (A) with/without radiotherapy, and (B) preoperative and postoperative radiotherapy.
Referenced by surgery-alone group, aP < 0.05; HR: Hazard ratio; NA: Not applicable.
- Citation: Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Second primary malignancy risk after radiotherapy in rectal cancer survivors. World J Gastroenterol 2018; 24(40): 4586-4595
- URL: https://www.wjgnet.com/1007-9327/full/v24/i40/4586.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i40.4586